Quantitation of human seroresponsiveness to Merkel cell polyomavirus

PLoS Pathogens

Volumn 5, Issue 9, 2009, Pages

  Pastrana, Diana V ^a   Tolstov, Yanis L ^b   Becker, Jürgen C ^c   Moore, Patrick S ^b   Chang, Yuan ^b   Buck, Christopher B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FREUND ADJUVANT; MERKEL CELL POLYOMAVIRUS VACCINE; NEUTRALIZING ANTIBODY; PROTEIN VP1; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS DNA; VIRUS VACCINE; CAPSID PROTEIN; VP1 PROTEIN, POLYOMAVIRUS; VP2 PROTEIN, POLYOMAVIRUS;

ADJUVANT THERAPY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BK VIRUS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; EMBRYO; FEMALE; GENE VECTOR; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOGENICITY; MALE; MERKEL CELL POLYOMAVIRUS; MERKEL CELL POLYOMAVIRUS INFECTION; MERKEL CELL TUMOR; POLYOMA VIRUS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REPORTER GENE; TUMOR GROWTH; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; ANIMAL; BLOOD; CELL LINE; ENZYME IMMUNOASSAY; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; PATHOGENICITY; RABBIT; SERODIAGNOSIS; VIROLOGY;

ANIMALIA; BK POLYOMAVIRUS; MIRIDAE; POLYOMAVIRUS;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CARCINOMA, MERKEL CELL; CELL LINE; GENES, REPORTER; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEUTRALIZATION TESTS; POLYOMAVIRUS; RABBITS;

EID: 70349693465     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000578     Document Type: Article

References (46)

1. Jiang M, Abend JR, Johnson SF, Imperiale MJ (2009) The role of polyomaviruses in human disease. Virology 384: 266-273.
2. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319: 1096-1100. (Pubitemid 351300792)
3. Becker JC, Schrama D, Houben R (2009) Merkel cell carcinoma. Cell Mol Life Sci 66: 1-8.
4. Buck CB, Lowy DR (2009) Getting stronger: the relationship between a newly identified virus and merkel cell carcinoma. J Invest Dermatol 129: 9-11.
5. Kassem A, Schopflin A, Diaz C, Weyers W, Stickeler E, et al. (2008) Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res 68: 5009-5013.
6. Becker JC, Houben R, Ugurel S, Trefzer U, Pfohler C, et al. (2008) MC Polyomavirus Is Frequently Present in Merkel Cell Carcinoma of European Patients. J Invest Dermatol.
7. Garneski KM, Warcola AH, Feng Q, Kiviat NB, Leonard JH, et al. (2008) Merkel Cell Polyomavirus Is More Frequently Present in North American than Australian Merkel Cell Carcinoma Tumors. J Invest Dermatol.
8. Duncavage EJ, Zehnbauer BA, Pfeifer JD (2009) Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod Pathol.
9. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, et al. (2008) T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A.
10. Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, et al. (2009) Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors. Int J Cancer In press.
11. Kean JM, Rao S, Wang M, Garcea RL (2009) Seroepidemiology of human polyomaviruses. PLoS Pathog 5: e1000363. doi:10.1371/journal.ppat.1000363.
12. Tolstov YL, Pastrana DV, Feng H, Becker JC, Jenkins FJ, et al. (2009) Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer. In Press.
13. Dessy FJ, Giannini SL, Bougelet CA, Kemp TJ, David MP, et al. (2008) Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine. Hum Vaccin 4: 425-434.
14. Goldmann C, Petry H, Frye S, Ast O, Ebitsch S, et al. (1999) Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: formation of virus-like particles useful for immunological and therapeutic studies. J Virol 73: 4465-4469. (Pubitemid 29189897)
15. Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78: 751-757.
16. Touze A, Gaitan J, Maruani A, Le Bidre E, Doussinaud A, et al. (2009) Merkel cell polyomavirus strains in patients with merkel cell carcinoma. Emerg Infect Dis 15: 960-962.
17. Brade L, Muller-Lantzsch N, zur Hausen H (1981) B-lymphotropic papovavirus and possibility of infections in humans. J Med Virol 6: 301-308.
18. Gilbert JM, Benjamin TL (2000) Early steps of polyomavirus entry into cells. J Virol 74: 8582-8588.
19. Andrewes CH, Elford WJ (1933) Observations on anti-phage sera. I.'The percentage law'. British Journal of Experimental Pathology 14: 367-376.
20. Burnet FM, Keogh EV, Lush D (1937) The immunological reactions of the filterable viruses. Aust J Exp Biol Med Sci 15: 227-368.
21. Klasse PJ, Sattentau QJ (2002) Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J Gen Virol 83: 2091-2108.
22. Mascola JR, Louder MK, Winter C, Prabhakara R, De Rosa SC, et al. (2002) Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J Virol 76: 4810-4821. (Pubitemid 34441687)
23. Pierson TC, Sanchez MD, Puffer BA, Ahmed AA, Geiss BJ, et al. (2006) A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346: 53-65.
24. Sashihara J, Burbelo PD, Savoldo B, Pierson TC, Cohen JI (2009) Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay. Virology.
25. Randhawa PS, Gupta G, Vats A, Shapiro R, Viscidi RP (2006) Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 13: 1057-1063. (Pubitemid 44518976)
26. Lundstig A, Dillner J (2006) Serological diagnosis of human polyomavirus infection. Adv Exp Med Biol 577: 96-101.
27. Randhawa P, Bohl D, Brennan D, Ruppert K, Ramaswami B, et al. (2008) longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients. Clin Vaccine Immunol 15: 1564-1571.
28. Nakanishi A, Chapellier B, Maekawa N, Hiramoto M, Kuge T, et al. (2008) SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids. Virology 379: 110-117.
29. Knowles WA, Pipkin P, Andrews N, Vyse A, Minor P, et al. (2003) Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 71: 115-123. (Pubitemid 37121921)
30. Chesters PM, Heritage J, McCance DJ (1983) Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 147: 676-684.
31. Chen Y, Trofe J, Gordon J, Du Pasquier RA, Roy-Chaudhury P, et al. (2006) Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol 80: 3495-3505.
32. Lundstig A, Stattin P, Persson K, Sasnauskas K, Viscidi RP, et al. (2007) No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus. Int J Cancer 121: 1098-1102.
33. Society AC (2007) Cancer Facts & Figures 2007. Atlanta: American Cancer Society.
34. Lemos B, Nghiem P (2007) Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol 127: 2100-2103. (Pubitemid 47258499)
35. Sharp CP, Norja P, Anthony I, Bell JE, Simmonds P (2009) Reactivation and Mutation of Newly Discovered WU, KI, and Merkel Cell Carcinoma Polyomaviruses in Immunosuppressed Individuals. J Infect Dis 199: 398-404.
36. Goh S, Lindau C, Tiveljung-Lindell A, Allander T (2009) Merkel cell polyomavirus in respiratory tract secretions. Emerg Infect Dis 15: 489-491.
37. Bialasiewicz S, Lambert SB, Whiley DM, Nissen MD, Sloots TP (2009) Merkel Cell Polyomavirus DNA in Respiratory Specimens from Children and Adults. Emerg Infect Dis 15: 492-494.
38. Kassem A, Technau K, Kurz AK, Pantulu D, Loning M, et al. (2009) Merkel cell polyomavirus sequences are frequently detected in nonmelanoma skin cancer of immunosuppressed patients. Int J Cancer 125: 356-361.
39. Dworkin AM, Tseng SY, Allain DC, Iwenofu OH, Peters SB, et al. (2009) Merkel Cell Polyomavirus in Cutaneous Squamous Cell Carcinoma of Immunocompetent Individuals. J Invest Dermatol.
40. Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, et al. (2006) Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia: A Randomized Controlled Trial. Obstet Gynecol 107: 18-27. (Pubitemid 43755499)
41. Pastrana DV, Gambhira R, Buck CB, Pang YY, Thompson CD, et al. (2005) Cross-neutralization of cutaneous and mucosal Papillomavirus types with antisera to the amino terminus of L2. Virology 337: 365-372. (Pubitemid 40803480)
42. Buck CB, Thompson CD (2007) Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol Chapter 26: Unit 26.21.
43. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT (2005) Maturation of papillomavirus capsids. J Virol 79: 2839-2846.
44. Grady L, Axelrod D, Trilling D (1970) The SV40 pseudovirus: its potential for general transduction in animal cells. Proc Natl Acad Sci U S A 67: 1886-1893.
45. Bishop CL, Ramalho M, Nadkarni N, May Kong W, Higgins CF, et al. (2006) Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA. Mol Cell Biol 26: 2583-2594.
46. Robertson D, Savage K, Reis-Filho JS, Isacke CM (2008) Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC Cell Biol 9: 13.